PL3452050T3 - Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej - Google Patents

Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej

Info

Publication number
PL3452050T3
PL3452050T3 PL17792540.1T PL17792540T PL3452050T3 PL 3452050 T3 PL3452050 T3 PL 3452050T3 PL 17792540 T PL17792540 T PL 17792540T PL 3452050 T3 PL3452050 T3 PL 3452050T3
Authority
PL
Poland
Prior art keywords
hmos
treatment
composition
infectious diarrhoea
diarrhoea
Prior art date
Application number
PL17792540.1T
Other languages
English (en)
Inventor
Bruce Mcconnell
Louise Kristine VIGSNÆS
Emma ELISON
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60202765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3452050(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US15/147,112 external-priority patent/US20160243138A1/en
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL3452050T3 publication Critical patent/PL3452050T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
PL17792540.1T 2016-05-05 2017-05-05 Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej PL3452050T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/147,112 US20160243138A1 (en) 2014-10-29 2016-05-05 Composition comprising HMSs/HMOs and use thereof
PCT/DK2017/050145 WO2017190754A1 (en) 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of non-infectious diarrhoea

Publications (1)

Publication Number Publication Date
PL3452050T3 true PL3452050T3 (pl) 2023-06-12

Family

ID=60202765

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17792540.1T PL3452050T3 (pl) 2016-05-05 2017-05-05 Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej

Country Status (5)

Country Link
EP (1) EP3452050B1 (pl)
DK (1) DK3452050T3 (pl)
ES (1) ES2938355T3 (pl)
PL (1) PL3452050T3 (pl)
WO (1) WO2017190754A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
DK3452050T3 (da) 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea
EP3716984B1 (en) 2017-11-30 2024-03-20 Glycom A/S Mixture of hmos for treating wheat sensitivity
EP3790997A4 (en) * 2018-05-09 2022-03-16 Carbiotix AB METHOD FOR MEASURING AND IMPROVING INTESTINAL HEALTH
CN113194960A (zh) * 2018-12-19 2021-07-30 格礼卡姆股份公司 用于治疗使用低fodmap饮食的人的组合物和方法
MX2021006189A (es) 2018-12-21 2021-06-23 Nestle Sa Una composicion nutricional que comprende 2'-fucasillactosa (2'fl) para mejorar la barrera gastrointestinal.
WO2020174386A1 (en) 2019-02-25 2020-09-03 Nutribam Bvba Composition, food supplement and method for supporting and/or improving intestinal health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
CA3161861A1 (en) * 2019-11-27 2021-06-03 Glycom A/S Mixture of hmos
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN115772489B (zh) * 2022-12-23 2025-06-24 江南大学 一种能够缓解抗生素相关性腹泻的复合微生态制剂
CN117286078B (zh) * 2023-11-21 2024-02-02 四川厌氧生物科技有限责任公司 一种改善胃肠道健康的植物乳植杆菌及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
WO2007101862A1 (en) 2006-03-09 2007-09-13 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
EP2405524B1 (en) 2009-03-05 2015-10-07 Nissan Motor Co., Ltd. Bipolar secondary cell and method for producing the same
CN102459294A (zh) 2009-04-07 2012-05-16 格礼卡姆股份公司 2’-o-岩藻糖基乳糖的合成
EP3241836B1 (en) 2010-02-19 2024-10-30 Glycom A/S Polymorph of a tetrasaccharide containing nacetyl-lactosamine
AU2011278236A1 (en) 2010-07-16 2013-02-07 Glycom A/S Derivatization of oligosaccharides
MY191538A (en) * 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
US20120171166A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
WO2012113404A1 (en) 2011-02-21 2012-08-30 Glycom A/S Novel glycosyl phosphites
CN103443113A (zh) 2011-03-18 2013-12-11 格力康公司 新型含岩藻糖的糖类衍生物的合成
CN103562214B9 (zh) 2011-05-13 2016-12-14 格力康公司 人乳寡糖(hmo)或其前体的多样化
CN103562401A (zh) 2011-05-13 2014-02-05 格力康公司 产生人乳寡糖(hmo)或其前体的方法
WO2012155916A1 (en) 2011-05-13 2012-11-22 Glycom A/S Manufacture of lacto-n-tetraose
HK1199607A1 (en) 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2760875A4 (en) 2011-09-30 2015-08-26 Glycom As SYNTHESIS OF HMO NUCLEAR STRUCTURES
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en) 2012-03-20 2013-09-26 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
CN104507483A (zh) * 2012-04-13 2015-04-08 波士顿学院理事会 益生元组合物及使用方法
WO2013161820A1 (ja) * 2012-04-23 2013-10-31 国立大学法人京都大学 ビフィズス菌の増殖促進用組成物
EP3082828B1 (en) 2013-11-15 2022-03-02 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
WO2015095747A1 (en) 2013-12-20 2015-06-25 Abbott Laboratories Oral rehydration composition with oligosaccharides
EP3125905A4 (en) 2014-04-04 2017-11-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
HK1231398A1 (zh) * 2014-04-08 2017-12-22 Abbott Laboratories 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
EP3212197A4 (en) * 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
EP3377071B1 (en) 2015-11-17 2024-01-10 Glycom A/S Human milk oligosaccharides for treating antibiotic associated complications
DK3452050T3 (da) 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea

Also Published As

Publication number Publication date
DK3452050T3 (da) 2023-02-20
ES2938355T3 (es) 2023-04-10
EP3452050A1 (en) 2019-03-13
WO2017190754A1 (en) 2017-11-09
EP3452050B1 (en) 2022-11-23
EP3452050A4 (en) 2020-01-08

Similar Documents

Publication Publication Date Title
IL264049A (en) Compounds, preparations and methods for treating the disease
PL3452050T3 (pl) Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
IL264156A (en) Compounds, preparations and methods for treating the disease
IL258002A (en) Cenicriviroc combination therapy for the treatment of fibrosis
EP3448874A4 (en) COMPOSITIONS FOR TREATING A DISEASE
IL253945A0 (en) kdm1a inhibitors to treat the disease
SI3261726T1 (sl) Sestavek za zdravljenje aken
IL259996A (en) Combinations for cancer treatment
IL258032B (en) Compounds and preparations for the treatment of ocular disorders
ZA201902781B (en) Compositions and methods for the treatment of xerostomia
IL249640A0 (en) Preparations for the treatment of nosebleeds
SI3302573T1 (sl) Sestavek za zdravljenje možganskih lezij
PL3122349T3 (pl) Kompozycje do leczenia samotrawienia
IL253617A0 (en) Snekribirock for the treatment of leprosy
GB201612043D0 (en) Composition for treatment of disorders
PL3484475T3 (pl) 1-Metylonikotynamid do leczenia choroby układu krążenia
PT3548006T (pt) Composição para utilização no tratamento de alterações intestinais
PT3340975T (pt) Formulação para o tratamento de acne
IL267059A (en) A preparation for the treatment of osteoarthritis
IL255167A0 (en) Compounds for the treatment of cancer
ZA201704589B (en) Compounds for the treatment of cancer
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
PL3273997T3 (pl) Kompozycja do leczenia nieżytu nosa
PT3524255T (pt) Composição para o tratamento do acne
GB201507040D0 (en) Treatment of the the symptoms of osteoarthritis